Organogenesis Holdings Inc. Insider Trading

ORGO

Last 12 months

Insiders bought 40K and sold $2.62M on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Glenn H Nussdorf sold $1.59M on Nov 26, 2025 outside a plan.

Net open-market

−$2.58M

2 buys · 2 sales

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

2 / 1

executives and directors

Last open-market buy

Mar 2026

Mar 9, 2026

Get an email when ORGO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Mar 9	Arthur S Leibowitz Director	Bought	5,000	$2.68	13K	1.7%	Form 4
Mar 9	Michael Joseph Driscoll Director	Bought	10,000	$2.67	27K	4.6%	Form 4
Dec 16, 2025	Glenn H Nussdorf Director	SoldNo plan	200,000	$5.14	$1.03M	1.7%	Form 4
Nov 24, 2025 – Nov 26, 2025	Glenn H Nussdorf Director	SoldNo plan 3 parts	300,000	$5.31 average	$1.59M	2.4%	Form 4
Jun 9, 2025 – Jun 10, 2025	Glenn H Nussdorf Director	SoldNo plan 2 parts	22,776	$3.55 average	81K	0.2%	Form 4
Jun 4, 2025 – Jun 6, 2025	Lori Freedman Chief Admin. and Legal Officer	Bought 3 parts	252,264	$2.88 average	726K	42%	Form 4
May 14, 2025 – May 15, 2025	Glenn H Nussdorf Director	Bought 2 parts	358,495	$3.06 average	$1.1M	3.0%	Form 4
Mar 4, 2025	Michael Joseph Driscoll Director	SoldNo plan	25,000	$5.10	128K	13%	Form 4
Dec 13, 2024 – Dec 16, 2024	Gary S. Gillheeney President and CEO	SoldNo plan 2 parts	61,200	$3.37 average	206K	2.0%	Form 4
Dec 10, 2024 – Dec 12, 2024	Gary S. Gillheeney President and CEO	SoldNo plan 3 parts	259,332	$3.62 average	940K	7.7%	Form 4
Dec 6, 2024 – Dec 9, 2024	Gary S. Gillheeney President and CEO	SoldNo plan 2 parts	59,468	$3.56 average	212K	1.7%	Form 4

Mar 9
Arthur S Leibowitz
Director · bought 5,000 at $2.68
13K
1.7% of stake
Mar 9
Michael Joseph Driscoll
Director · bought 10,000 at $2.67
27K
4.6% of stake
Dec 16, 2025No plan
Glenn H Nussdorf
Director · sold 200,000 at $5.14
$1.03M
1.7% of stake
Nov 24, 2025 – Nov 26, 2025No plan
Glenn H Nussdorf
Director · sold 300,000 at avg $5.31
$1.59M
2.4% of stake
Jun 9, 2025 – Jun 10, 2025No plan
Glenn H Nussdorf
Director · sold 22,776 at avg $3.55
81K
0.2% of stake
Jun 4, 2025 – Jun 6, 2025
Lori Freedman
Chief Admin. and Legal Officer · bought 252,264 at avg $2.88
726K
42% of stake
May 14, 2025 – May 15, 2025
Glenn H Nussdorf
Director · bought 358,495 at avg $3.06
$1.1M
3.0% of stake
Mar 4, 2025No plan
Michael Joseph Driscoll
Director · sold 25,000 at $5.10
128K
13% of stake
Dec 13, 2024 – Dec 16, 2024No plan
Gary S. Gillheeney
President and CEO · sold 61,200 at avg $3.37
206K
2.0% of stake
Dec 10, 2024 – Dec 12, 2024No plan
Gary S. Gillheeney
President and CEO · sold 259,332 at avg $3.62
940K
7.7% of stake
Dec 6, 2024 – Dec 9, 2024No plan
Gary S. Gillheeney
President and CEO · sold 59,468 at avg $3.56
212K
1.7% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ORGO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ORGO

CompareIntrinsic value

CRMDCorMedix Inc.

$5.66+1.80%84

ARQTArcutis Biotherapeutics Inc.

$34.05+6.41%65

LQDALiquidia Corporation

$47.38+12.27%72

ARDXArdelyx Inc.

$3.27+7.92%40

ZLABZai Lab Ltd

$22.80+3.83%40

INVAInnoviva Inc.

$21.26+1.58%56

NATRNature's Sunshine Products Inc.

$12.84+6.38%70

ESPREsperion Therapeutics Inc.

No recent price50

Held by ETFs

ORGO is in 9 US ETFs. The largest of them, with ORGO's weight in each:

Spot a number that looks wrong? Check it in ORGO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ORGO

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.